Polysomnographic Pattern of Melatonin Therapy in Perimenopausal Women

Irina Madaeva, Natalya Semenova, Radzhana M. Zhambalova, Lyubov I. Kolesnikova, Sergey I. Kolesnikov

International Journal of Biomedicine. 2020;10(2):161-164.
DOI: 10.21103/Article10(2)_OA15
Originally published June 15, 2020.


Background: Earlier, we described our own study results of the chronobiological circadian rhythm of salivary fluid melatonin secretion in menopausal women, which allowed us pathogenetically to substantiate the use of melatonin drugs for insomnia in the perimenopausal period. The aim of this research was to evaluate the sleep quality using polysomnographic monitoring in perimenopausal women with sleep disorders (SDs) before and after 3 months of melatonin therapy.
Methods and Results: The study involved 21 perimenopausal women with complaints of SDs. All women completed a questionnaire to assess the subjective severity of insomnia (Insomnia Severity Index, ISI) and underwent a clinical-anamnestic and gynecological examination. Polysomnography (PSG) was performed before and after 3 months melatonin therapy in a daily dose of 3 mg. After melatonin intake, PSG demonstrated improvement in sleep latency, overall sleep efficiency, and an increase of REM sleep. A statistically significant number of EEG activation reactions indicate a decrease in sleep fragmentation and an improvement in sleep segmental structure.
Conclusions: The use of melatonin in a dose of 3mg/day for 3 months is one of the main methods for treatment of SDs in age-related estrogen-deficient situations. The main clinical effect, which significantly improves the quality of life, is associated with the elimination of pre- and intrasomnic disorders.

polysomnography • melatonin • perimenopausal women • sleep • insomnia
  1. Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, Meyer PM. Sleep difficulty in women at midlife: A community survey of sleep and the menopausal transition. Menopause. 2003;10(1):19-28. doi:10.1097/00042192-200301000-00005
  2. Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep 2004;27(7):1255-73.60-61. doi:10.1093/sleep/27.7.1255
  3. Young T, Rabago D, Zgierska A, Austin D.,  Finn L. Objective and subjective sleep quality in premenopausal, perimenopausal, and postmenopausal women in the Wisconsin Sleep Cohort Study. Sleep 2003;26:667-72 doi:10.1093/sleep/26.6.66
  4. Zhang B, Wing YK. Sex differences in insomnia: a meta-analysis. Sleep. 2006; 29(1):85-93.2. doi:10.1093/sleep/29.1.85
  5. Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova I, Ben-Shushan A, Ford I. Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev. 2005;9(1):41-50. doi:10.1016/j.smrv.2004.06.004
  6. Sack RL, Auckley D, Auger RR, Carskadon MA, Wright KP Jr, Vitiello MV, Zhdanova IV; American Academy of Sleep Medicine. Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine Sleep review. 2007;30(11):1484-1501. doi:10.1093/sleep/30.11.1484
  7. Rozen TD. Melatonin as a treatment for idiopathic stabbing headache. Neurology. 2003;61:865-866. doi: 10.1212/01.WNL.0000082388.03466.
  8. Magri F, Sarra S, Cinchetti W, Guazzoni V, Floravanti M, Cravello L, Ferrari E. Qualitative and quantitative change of melatonin levels in physiological aging and in centenarians. J Pineal Res. 2004;36(4):256-261. doi:10.1111/j.1600-079x.2004.00125.x
  9. Eichling PS, Sahni J. Menopause related sleep disorders J Clin Sleep Med. 2005;1(3):291-300 
  10. Geoffroy PA, Etain B, Franchi JA, Bellivier F, Ritter P. Melatonin and Melatonin Agonists as Adjunctive Treatments in Bipolar Disorders. Curr Pharm Des. 2015;21(23):3352-8.
  11. Poluéktov MG, Levin IaI, Boĭko AN, Skoromets AA, Bel'skaia GN, Gustov AV, et al. [The results of Russian multicenter open-label observational study of the efficacy and safety of мelaxen (melatonin) for the treatment of disordered sleep in patients with chronic cerebral ischemia]. Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(9):26-31. [Article in Russian].
  12. Attarian H, Hachul H, Guttuso T, Phillips B. Treatment of chronic insomnia disorder in menopause: evaluation of literature. Menopause. 2015;22(6):674-84. doi: 10.1097/GME.0000000000000348.
  13. Poluéktov MG, Buzunov RV, Averbukh VM, Verbitsky EV, Zaharov AV, Kelmanson IA, et al.  [Project of guideline for treatment insomnia].  Supplement to the Journal Consilium Medicum (Neurology and Rheumatology). 2016;(2):41-51.[Article in Russian].
  14. Madaeva IM, Semenova NV, Kolesnikova LI, Berdina ON, Solodova EI.[Insomniac disorders in post menopause women]. Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(11):81-4.[Article in Russian].
  15. Morin CM, Belleville G, Bélanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601-8.
  16. Attarian H, Hachul H, Guttuso T, Phillips B. Treatment of chronic insomnia disorder in menopause: evaluation of literature. Menopause. 2015;22(6):674-84. doi: 10.1097/GME.0000000000000348.
  17. Chojnacki C, Kaczka A, Gasiorowska A, Fichna J, Chojnacki J, Brzozowski T. The effect of long-term melatonin supplementation on psychosomatic disorders in postmenopausal women. J Physiol Pharmacol. 2018;69(2). doi: 10.26402/jpp.2018.2.15..
  18. Shapiro CM,   Flanigan MJ. Function  of  sleep. In Shapiro CM (ed.). ABC of Sleep Disorders. London, BMJ Publishing Group; 1993: 5-7. doi:10.1136/bmj.306.6874.383
  19. Kamble N, Yadav R, Lenka A, Kumar K, Nagaraju BC, Pal PK. Impaired sleep quality and cognition in patients of Parkinson's disease with REM sleep behavior disorder: a comparative study. Sleep Med. 2019;62:1-5. doi: 10.1016/j.sleep.2019.04.00
  20. Baglioni C, Nanovska S, Regen W, Spiegelhalder K, Feige B, Nissen C, Reynolds CF, Riemann D. Sleep and mental disorders: A meta-analysis of polysomnographic research.  Psychol Bull. 2016;142(9):969-990.
  21. Semenova NV, Madaeva IM, Kolesnikova LI, Berdina ON, Solodova EI, Sholokhov LF. Hormonal-metabolic parameters in perimenopausal women with sleep disorders. Journal of Sleep Research. 2014;23(s1):239.

Download Article
Received January 15, 2020.
Accepted March 16, 2020.
©2020 International Medical Research and Development Corporation.